In conjunction with the North American Neuro-Ophthalmology Society (NANOS)
When Should I Worry? Dangerous Signs, Symptoms, and Findings in Neuro-Ophthalmology
Saturday, Nov. 11, 2017
La Nouvelle Orleans Ballroom C, Ernest N. Morial Convention Center
Schedule and Syallbus
2017 Schedule
Neuro-Ophthalmology Subspecialty Day 2017: When Should I Worry? Dangerous Signs, Symptoms, and Findings in Neuro-Ophthalmology (PDF 1.7MB)
Program Directors
Michael S. Lee, MD; Prem S. Subramanian, MD, PhD
Program Planning Group
Anne Abel, MD; Rudrani Banik, MD; Valerie Biousse, MD; Dean M. Cestari, MD; Sophia Chung, MD; Sarita Dave, MD; Mays A. El-Dairi, MD; John J. Chen, MD, PhD; Julie Falardeau, MD; Matthew Dean Kay, MD; Andrew G. Lee, MD; Michael S. Lee, MD; Collin McClelland, MD; Mitchell Strominger, MD; Prem S. Subramanian, MD, PhD
Mission Statement
The mission of the 2017 AAO-NANOS Neuro-Ophthalmology Subspecialty Day is to provide new, updated, and clinically relevant neuro-ophthalmic information that will assist the practicing ophthalmologist identify critical findings necessary to make an accurate diagnosis and determine management strategies based on best practices.
What is the professional practice gap that this activity will address?
Neuro-ophthalmic presentations may mimic or be mistaken for benign conditions. The comprehensive ophthalmologist must listen for the significant and critical historical symptom, look for the distinctive clinical sign, and identify the differentiating or diagnostic radiographic or laboratory feature that may be vision- or life-saving for the patient. Successful diagnosis and treatment depend on focusing the history and exam are focusing the history and exam, rapidly prioritizing the differential diagnosis, and making a triage decision regarding the urgency of the problem. The clinical situations that can challenge the practicing ophthalmologist include ptosis, optic disc edema, anisocoria, visual field abnormalities, eye movements, vision loss, interpretation of tests relevant to the clinical presentation, and diplopia. The patient’s systemic conditions also must be understood by the ophthalmologist to recognize the associated neuro-ophthalmic findings.
Target Audience
The intended audience for this program is comprehensive ophthalmologists.
Education Level
Beginner, intermediate, and advanced concepts will be discussed to offer sufficient breadth and depth to the target audience.
Goal
At the conclusion of this symposium, the attendee will recognize neuro-ophthalmic signs or symptoms critical to an accurate diagnosis and will be able to determine best initial management based on best practices.
Program Objectives
Upon completion of this activity, participants should be able to:
- Recognize urgent signs and symptoms in the evaluation of adults with diplopia
- Direct the initial workup of a patient with visual loss from optic neuropathy
- Distinguish the key neuro-ophthalmic manifestations of systemic diseases affecting visual function
- Determine when and how to order and interpret diagnostic testing studies for ophthalmic conditions
CME Accreditation
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses or guests are not eligible for CME credits.
Find more information about CME.